McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.
Industry, Sector and Symbol
Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
Phone415-983-8300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$208.36 billion
Profitability
Miscellaneous
Employees78,000
Next Earnings Date5/23/2019 (Estimated)
OptionableOptionable
McKesson (NYSE:MCK) Frequently Asked Questions
What is McKesson's stock symbol?
McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."
How often does McKesson pay dividends? What is the dividend yield for McKesson?
McKesson announced a quarterly dividend on Thursday, January 31st. Stockholders of record on Friday, March 1st will be paid a dividend of $0.39 per share on Monday, April 1st. This represents a $1.56 annualized dividend and a dividend yield of 1.34%. The ex-dividend date is Thursday, February 28th. View McKesson's Dividend History.
How were McKesson's earnings last quarter?
McKesson Co. (NYSE:MCK) released its quarterly earnings results on Thursday, January, 31st. The company reported $3.40 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $3.18 by $0.22. The company earned $56.21 billion during the quarter, compared to analyst estimates of $55.27 billion. McKesson had a positive return on equity of 27.83% and a negative net margin of 0.15%. During the same quarter last year, the firm posted $3.41 earnings per share. View McKesson's Earnings History.
When is McKesson's next earnings date?
What guidance has McKesson issued on next quarter's earnings?
McKesson updated its FY19 earnings guidance on Thursday, January, 31st. The company provided EPS guidance of $13.45-13.65 for the period, compared to the Thomson Reuters consensus EPS estimate of $13.40.
What price target have analysts set for MCK?
13 brokerages have issued 1-year target prices for McKesson's stock. Their predictions range from $2.86 to $175.00. On average, they anticipate McKesson's stock price to reach $137.4418 in the next year. This suggests a possible upside of 18.0% from the stock's current price. View Analyst Price Targets for McKesson.
What is the consensus analysts' recommendation for McKesson?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 8 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for McKesson.
Has McKesson been receiving favorable news coverage?
Press coverage about MCK stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. McKesson earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days.
Who are some of McKesson's key competitors?
What other stocks do shareholders of McKesson own?
Who are McKesson's key executives?
McKesson's management team includes the folowing people:
- Mr. John H. Hammergren, Chairman & CEO (Age 60)
- Ms. Marie L. Knowles, Independent Director (Age 73)
- Britt J. Vitalone, CFO & Exec. VP (Age 50)
- Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
- Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
Who are McKesson's major shareholders?
McKesson's stock is owned by a number of of institutional and retail investors. Top institutional investors include BlackRock Inc. (8.22%), Oregon Public Employees Retirement Fund (4.31%), Massachusetts Financial Services Co. MA (2.88%), Boston Partners (2.79%), FMR LLC (2.28%) and Nordea Investment Management AB (1.71%). Company insiders that own McKesson stock include Erin M Lampert, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles and N Anthony Coles. View Institutional Ownership Trends for McKesson.
Which major investors are selling McKesson stock?
MCK stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Baupost Group LLC MA, Hsbc Holdings PLC, Millennium Management LLC, Bank of New York Mellon Corp, Unigestion Holding SA, Scharf Investments LLC and Great West Life Assurance Co. Can. Company insiders that have sold McKesson company stock in the last year include Erin M Lampert, Lori A Schechter and N Anthony Coles. View Insider Buying and Selling for McKesson.
Which major investors are buying McKesson stock?
MCK stock was bought by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Norges Bank, CI Investments Inc., Massachusetts Financial Services Co. MA, River & Mercantile Asset Management LLP, BlackRock Inc., RWC Asset Management LLP and RWC Asset Management LLP. View Insider Buying and Selling for McKesson.
How do I buy shares of McKesson?
Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is McKesson's stock price today?
One share of MCK stock can currently be purchased for approximately $116.45.
How big of a company is McKesson?
McKesson has a market capitalization of $22.34 billion and generates $208.36 billion in revenue each year. The company earns $67 million in net income (profit) each year or $12.62 on an earnings per share basis. McKesson employs 78,000 workers across the globe.
What is McKesson's official website?
How can I contact McKesson?
McKesson's mailing address is ONE POST ST MCKESSON PLAZA, SAN FRANCISCO CA, 94104. The company can be reached via phone at 415-983-8300 or via email at [email protected]
MarketBeat Community Rating for McKesson (NYSE MCK)
MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote "Outperform" if you believe MCK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.
